Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV) Infection”

1,448 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,448 results

Large-scale testing (Phase 3)Study completedNCT01297270
What this trial is testing

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 658
Not applicableLooking for participantsNCT05870969
What this trial is testing

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

Who this might be right for
Carcinoma, HepatocellularHepatitis C, ChronicHepatitis B, Chronic+2 more
Ruijin Hospital 20,000
Not applicableStudy completedNCT00709059
What this trial is testing

Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 538
Testing effectiveness (Phase 2)Study completedNCT00874770
What this trial is testing

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin)

Who this might be right for
Hepatitis C Infection
Bristol-Myers Squibb 74
Not applicableStudy completedNCT04577482
What this trial is testing

Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 42
Large-scale testing (Phase 3)Study completedNCT01343888
What this trial is testing

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 1)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 656
Testing effectiveness (Phase 2)UnknownNCT01024894
What this trial is testing

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy

Who this might be right for
Hepatitis C
Cytheris SA 15
Not applicableStudy completedNCT02582658
What this trial is testing

Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL)

Who this might be right for
Chronic Hepatitis C
AbbVie 173
Testing effectiveness (Phase 2)UnknownNCT01727934
What this trial is testing

Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Santaris Pharma A/S 10
Not applicableStudy completedNCT03341871
What this trial is testing

Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 1,095
Not applicableUnknownNCT01360892
What this trial is testing

Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography

Who this might be right for
Chronic Hepatitis BChronic Hepatitis C
Kindai University 1,000
Large-scale testing (Phase 3)Study completedNCT01448044
What this trial is testing

Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 152
Post-approval studies (Phase 4)Ended earlyNCT01465919
What this trial is testing

Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C

Who this might be right for
Depression
Seoul National University Boramae Hospital 5
Not applicableEnrolling By InvitationNCT02699736
What this trial is testing

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

Who this might be right for
HIVHepatitis BHepatitis C+10 more
Rigshospitalet, Denmark 23,000
Large-scale testing (Phase 3)Study completedNCT00381953
What this trial is testing

High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV

Who this might be right for
Hepatitis C
Foundation for Liver Research 33
Not applicableStudy completedNCT02629172
What this trial is testing

Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1

Who this might be right for
Chronic Hepatitis C Virus
AbbVie 3,043
Large-scale testing (Phase 3)Ended earlyNCT00423800
What this trial is testing

Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 56
Testing effectiveness (Phase 2)Study completedNCT01795911
What this trial is testing

Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 165
Not applicableStudy completedNCT01066819
What this trial is testing

PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,656
Testing effectiveness (Phase 2)WithdrawnNCT01579019
What this trial is testing

RO5024048 in Combination With Ritonavir-Boosted Danoprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C Genotype 1 Who Have Failed Prior HCV Protease Inhibitor Treatment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche
Load More Results